CHDR
CHDR is an independent, full-service CRO and clinical site in Leiden, the Netherlands, specialising in Phase I and early Phase IIa drug development. We combine clinical pharmacology with pharmacodynamic biomarkers and experimental models, including pain models, to evaluate new treatments in healthy participants and patients. Our integrated approach provides insight into safety, pharmacokinetics and pharmacodynamics to support informed development decisions.
